5Maeda K,Okubo K,Shimomura I, et al. cDNA cloning andexpression of a novel adipose specific collagen-like factor, apMl(AdiPose Most abundant Gene transcript 1) [ J]. Biochem BiophysRes Commun,1996,221(2) :286-289.
6Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation andcharacterization of GBP28,a novel gelatin-binding protein purifiedfrom human plasma [J]. J Biochem,1996,120(4) :803-812.
7Takahashi M, Arita Y, Yamagata K, et al. Genomic structure andmutations in adipose-specific gene, adiponectin [J]. Int J ObesRelat Metab Disorcl,2000,24(7) :861-868.
8Yamauchi T, Kamon J, Waki H, et al. Globular adiponectinprotected ob/ob mice from diabetes and ApoE-deficient mice fromatherosclerosis [ J]. J Biol Chem,2003,278(4) :2461-2468.
9Fruebis J,Tsao TS,Javorschi S, et al. Proteolytic cleavage productof 30-kDa adipocyte complement-related protein increases fatty acidoxidation in muscle and causes weight loss in mice [J]. Proc NatlAcad Sci U S A,2001,98(4) :2005-2010.
10Waki H,Yamauchi T,Kamon J,et al. Impaired multimerization ofhuman adiponectin mutants associated with diabetes. Molecularstructure and multimer formation of adiponectin [ J]. J Biol Chem,2003 ,278(41) :4035240363.
7[1]Lindsay RS,Funahashi T,Hanson RL,et al.Adiponectin and development of type 2 diabetes in the Pima Indian population[J].Lancet,2002,360(9326):57-58.
8[2]Daimon M,Oizumi T,Saitoh T,et al.Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population:the Funagata study[J].Diabetes Care,2003,26(7):2015-2020.
9[3]Kondo H,Shimomura I,Matsukawa Y,et al.Association of adiponectin mutation with type 2 diabetes:a candidate gene for the insulin resistance syndrome[J].Diabetes,2002,51(7):2325-2328.
10[4]Arita Y,Kihara S,Ouchi N,et al.Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell[J].Circulation,2002,105(24):2893-2898.
4The ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(8):2560-2572.
5The ACCORD Study Group.Effects of intensive glucose lowsering iu type 2 diabetes[J].N Engl J Med,2008,358(9):2545-2559.
6Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multifacto-rlal intervention on mortality in type 2 diabetes [ J ].N Engl Fed,2008,358(22):580-591.
7Ribeiro-Filho FF,Faria AN,Azjen S,et al.Methods of estimation of visceral fat:advantages of ultrasonography[J].Obes Res,2003,11 (12):1488-1494.
8Holmes DR Jr,Elveback LR,Frye RL,et al.Association of risk factor variables and coronary artery disease documented with angiography[J].Circulation,1981,63 (2):293-299.
10Xu A,Chant KW,Hoo RL,et al.(2005) Testosterone selectively reduces the high Molecular weight form of adiponectin by inhibiting its secretion from adipocytes[J].J Biol Chem,2005,280(18):18073-18080.
